Immune-Onc Therapeutics launched in September 2016 and is headquartered in Palo Alto, California. Source: BioSpace

Lilly finally revealed the data in the New England Journal of Medicine. Source: BioSpace

After a brief stumble with UCART123 that resulted in a clinical hold last year, Cellectis is moving on with its study. Source: BioSpace

Spark won approval on Dec. 2017 as a one-time gene therapy to restore functional vision in children and adult patients with biallelic mutations of the RPE65. Source: BioSpace

Biotech and pharma execs Robert Mulroy and Dr. Debasish Roychowdhury announced today the launch of Partner Therapeutics, or PTx. Source: BioSpace

Significant risk remains for companies that cannot move quickly enough to positively impact R&D productivity and for those that encounter challenges in accessing technology and expertise that likely lie outside…

Novo has tried to apply pressure, but the ABLX board and principal shareholder have not been moved. Source: BioSpace

Headquartered in South San Francisco, Surrozen focuses on developing drugs by leveraging insights into the Wnt signaling pathway. Source: BioSpace

Here are five possible acquisition targets to keep an eye on. Source: BioSpace

Narasimhan takes over the role of CEO in February as current CEO Joe Jimenez retires. Source: BioSpace